| SYNE1 altered in cohorts of …ALTERED_INderived29 of 29show fewer |
|---|
| → altered in cohorts of | Cutaneous Melanoma 341 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 82 / 126 cases (65 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 32 / 83 cases (39 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 151 / 484 cases (31 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 122 / 429 cases (28 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 134 / 518 cases (26 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 35 / 144 cases (24 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 44 / 185 cases (24 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 37 / 158 cases (23 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 35 / 155 cases (23 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 27 / 120 cases (23 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 253 / 1,144 cases (22 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 114 / 517 cases (22 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 54 / 247 cases (22 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 101 / 478 cases (21 %) · ssm · stad_tcga · largest of 6 cohorts | — | — | Gastric Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 85 / 515 cases (17 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 147 / 1,015 cases (14 %) · ssm · crc_sysucc_2022 · largest of 5 cohorts | — | — | Colorectal Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 81 / 566 cases (14 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 66 / 474 cases (14 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Ampulla of Vater Carcinoma 21 / 160 cases (13 %) · ssm · ampca_bcm_2016 | — | — | Ampulla of Vater Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 37 / 291 cases (13 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 60 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 294 / 2,433 cases (12 %) · ssm · brca_metabric · largest of 6 cohorts | — | — | Invasive Breast Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 46 / 417 cases (11 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 25 / 297 cases (8.4 %) · ssm · mbn_sfu_2023 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 47 / 629 cases (7.5 %) · ssm · difg_glass · largest of 3 cohorts | — | — | Diffuse Glioma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 73 / 1,013 cases (7.2 %) · ssm · prad_p1000 · largest of 4 cohorts | — | — | Prostate Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Pancreatic Adenocarcinoma 27 / 383 cases (7.0 %) · ssm · paad_qcmg_uq_2016 | — | — | Pancreatic Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 51 / 961 cases (5.3 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |